University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven

New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension (2021) Stone JH, Spotswood H, Unizony SH, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Journal article Endoscopic tissue sampling - Part 2: Lower gastrointestinal tract. European Society of Gastrointestinal Endoscopy (ESGE) Guideline (2021) Pouw RE, Bisschops R, Gecse KB, De Hertogh G, Iacucci M, Rutter M, Barret M, et al. Journal article Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes (2021) Polhemus A, Ortiz LD, Brittain G, Chynkiamis N, Salis F, Gaßner H, Gross M, et al. Journal article, Review article Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis (2021) Escala-Garcia M, Canisius S, Keeman R, Beesley J, Anton-Culver H, Arndt V, Augustinsson A, et al. Journal article Obstructed defaecation syndrome: European consensus guidelines on the surgical management (2021) Picciariello A, O'Connell PR, Hahnloser D, Gallo G, Munoz-Duyos A, Schwandner O, Sileri P, et al. Journal article ECCO Topical Review: Refractory Inflammatory Bowel Disease (2021) Raine T, Verstockt B, Kopylov U, Karmiris K, Goldberg R, Atreya R, Burisch J, et al. Journal article, Review article PHENOCOPIESOF CLINICALLY DIAGNOSED ARPKD REVEALED IN CHILDREN (2021) Halawi A, Burgmaier K, Buescher A, Dursun I, Galiano M, Gessner M, Gokce I, et al. Conference contribution Endoscopic tissue sampling - Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline (2021) Pouw RE, Barret M, Biermann K, Bisschops R, Czako L, Gecse KB, De Hertogh G, et al. Journal article Myositis-specific and myositis-associated autoantibodies predict trajectories of damage over time in idiopathic inflammatory myopathies (2021) Espinosa-Ortega F, Holmqvist M, Lodin K, Dastmalchi M, Danieli MG, Venkovsky J, Knitza J, et al. Conference contribution Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival (2021) Slamon DJ, Neven P, Chia S, Jerusalem G, De Laurentiis M, Im S, Petrakova K, et al. Journal article